Login to Your Account

Other News To Note

Wednesday, December 22, 2010
Merck Serono, the pharmaceutical division of Merck KGaA, of Darmstadt, Germany, signed a deal with Philochem AG, of Zurich, Switzerland, in which Philochem will supply specific monoclonal antibodies to Merck Serono, to be used in the search for molecular biomarkers of oocyte and embryo quality for a test to be used by physicians. Terms of the agreement were not disclosed.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription